James F Tessmer - Net Worth and Insider Trading
James F Tessmer Net Worth
The estimated net worth of James F Tessmer is at least $85,402 dollars as of 2024-11-13. James F Tessmer is the VP, Finance & Accounting of Lexicon Pharmaceuticals Inc and owns about 71,766 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $85,402. Details can be seen in James F Tessmer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James F Tessmer has not made any transactions after 2021-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James F Tessmer
James F Tessmer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James F Tessmer owns 1 companies in total, including Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of James F Tessmer’s form 4 insider trades.
Insider Ownership Summary of James F Tessmer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2021-03-15 | VP & Finance & Acctg |
James F Tessmer Latest Holdings Summary
James F Tessmer currently owns a total of 1 stock. James F Tessmer owns 71,766 shares of Lexicon Pharmaceuticals Inc (LXRX) as of March 15, 2021, with a value of $85,402.
Latest Holdings of James F Tessmer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2021-03-15 | 71,766 | 1.19 | 85,402 |
Holding Weightings of James F Tessmer
James F Tessmer Form 4 Trading Tracker
According to the SEC Form 4 filings, James F Tessmer has made a total of 1 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the sale of 22,912 shares on March 15, 2021, which brought James F Tessmer around $158,551.
Insider Trading History of James F Tessmer
- 1
James F Tessmer Trading Performance
GuruFocus tracks the stock performance after each of James F Tessmer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James F Tessmer is 229.17%. GuruFocus also compares James F Tessmer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James F Tessmer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James F Tessmer's insider trading performs compared to the benchmark.
Performance of James F Tessmer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10 | | | | | |
| Relative Return to S&P 500(%) | 10.19 | | | | | |
James F Tessmer Ownership Network
Ownership Network List of James F Tessmer
Ownership Network Relation of James F Tessmer
James F Tessmer Owned Company Details
What does Lexicon Pharmaceuticals Inc do?
Who are the key executives at Lexicon Pharmaceuticals Inc?
James F Tessmer is the VP & Finance & Acctg of Lexicon Pharmaceuticals Inc. Other key executives at Lexicon Pharmaceuticals Inc include director & President and CEO Lonnel Coats , director & 10 percent owner Raymond Debbane , and SVP & Chief Commercial Officer Thomas Garner .
Lexicon Pharmaceuticals Inc (LXRX) Insider Trades Summary
Over the past 18 months, James F Tessmer made no insider transaction in Lexicon Pharmaceuticals Inc (LXRX). Other recent insider transactions involving Lexicon Pharmaceuticals Inc (LXRX) include a net purchase of 170,000 shares made by Lonnel Coats , a net purchase of 22,000 shares made by Jeffrey L Wade , and a net purchase of 16,000 shares made by Wendy Mcdermott .
In summary, during the past 3 months, insiders sold 0 shares of Lexicon Pharmaceuticals Inc (LXRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexicon Pharmaceuticals Inc (LXRX) were sold and 29,183,050 shares were bought by its insiders, resulting in a net purchase of 29,183,050 shares.
Lexicon Pharmaceuticals Inc (LXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexicon Pharmaceuticals Inc Insider Transactions
James F Tessmer Mailing Address
Above is the net worth, insider trading, and ownership report for James F Tessmer. You might contact James F Tessmer via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
